MedTrace Logo

Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin

NCT01354704 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2015-11-03

No results posted yet for this study

Summary

The objectives of the study are:

o Objective ultrasound: Determine the presence or absence of subclinical DVT in practicing ultrasound-Doppler Day7 and Day35, patients who underwent TKA or THA

o Clinical objective To evaluate the efficacy and tolerability clinical Enox ® in these patients compared with the original drug Lovenox ®.

Conditions

  • Deep Vein Thrombosis
  • Venous Thrombosis
  • Adverse Effect of Anticoagulants

Interventions

DRUG

Enoxaparin

enoxaparin 4000 IU 1 injection/day in subcutaneous.

Sponsors & Collaborators

  • Hopital Charles Nicolle

    collaborator OTHER

  • Les Laboratoires des Médicaments Stériles

    lead INDUSTRY

Principal Investigators

  • mondher kooli, MD · Hospital Charles Nicolle

  • Ramzi Bouzidi, MD · Hospital Charle Nicolle

  • Mustapha Azaiz, MD · Delta Medical Center

  • Abdelaziz Zarrouk, MD · Hospital Charles Nicollle

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2015-07-31
Completion
2015-10-31

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01354704 on ClinicalTrials.gov